SCHEMBL4956404

SCHEMBL4956404

NC(=S)NS(N)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27506920 0.78 ALDH1A1 (0.39)
SCHEMBL9293271 0.77
SCHEMBL16833520 0.77
SCHEMBL8611235 0.75
SCHEMBL18669917 0.75
SCHEMBL8956297 0.73
SCHEMBL11390149 0.73
SCHEMBL8524206 0.73 ALDH1A1 (0.35)
SCHEMBL161898 0.71
SCHEMBL2565947 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080038349-A1 Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase ITSCHAK LAMENSDORF 2008-02-14 US claimed
EP-1680439-A2 DUAL PHASE-PNA CONJUGATES FOR THE DELIVERY OF PNA THROUGH THE BLOOD BRAIN BARRIER Kernel Biopharma Inc. (IL) 2006-07-19 EP claimed
EP-1680438-A2 AMIPHIPHYLIC PEPTIDE-PNA CONJUGATES FOR THE DELIVERY OF PNA THROUGH THE BLOOD BRAIN BARRIER Kernel Biopharma Inc. (IL) 2006-07-19 EP claimed
US-20060142227-A1 Amphiphylic peptide-PNA conjugates for the delivery of PNA through the blood brain barrier LAMENSDORF ITSCHAK 2006-06-29 US claimed
US-20050222009-A1 Dual phase - PNA conjugates for the delivery of PNA through the blood brain barrier LAMENSDORF ITSCHAK 2005-10-06 US claimed
WO-2005076732-A2 PEPTIDE-PNA CHIMERA TARGETING INDUCIBLE NITRIC OXIDE SYNTHASE KERNEL BIOPHARMA INC. (IL) 2005-08-25 WO claimed
WO-2005035550-A2 DUAL PHASE-PNA CONJUGATES FOR THE DELIVERY OF PNA THROUGH THE BLOOD BRAIN BARRIER KERNEL BIOPHARMA INC. (IL) 2005-04-21 WO claimed
WO-2005035549-A2 AMIPHIPHYLIC PEPTIDE-PNA CONJUGATES FOR THE DELIVERY OF PNA THROUGH THE BLOOD BRAIN BARRIER KERNEL BIOPHARMA INC. (IL) 2005-04-21 WO claimed
EP-0159533-A2 Thiatriazine derivatives HOECHST UK LIMITED (GB) 1985-10-30 EP claimed
CN-113493540-B Cyclic diene copolymer 克拉通聚合物研究有限公司 2024-07-12 CN disclosed
US-20150259566-A1 METHODS FOR PROVIDING A LOW GLOSS POLYURETHANE COATING ON A SUBSTRATE BAYER MATERIALSCIENCE LLC (US) 2015-09-17 US disclosed
WO-2015138227-A1 METHODS FOR PROVIDING A LOW GLOSS POLYURETHANE COATING ON A SUBSTRATE BAYER MATERIALSCIENCE LLC (US) 2015-09-17 WO disclosed
US-20080038349-A1 Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase ITSCHAK LAMENSDORF 2008-02-14 US disclosed
EP-1680439-A2 DUAL PHASE-PNA CONJUGATES FOR THE DELIVERY OF PNA THROUGH THE BLOOD BRAIN BARRIER Kernel Biopharma Inc. (IL) 2006-07-19 EP disclosed
US-20020115107-A1 Pharmacophore recombination for the identification of small molecule drug lead compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-08-22 US disclosed
US-6344334-B1 DETECTION OF LEAD DRUG LIGANDS SUCH AS PROTEINS, NUCLEIC ACIDS OR SACCHARIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-02-05 US disclosed
EP-1066522-A1 PHARMACOPHORE RECOMBINATION FOR THE IDENTIFICATION OF SMALL MOLECULE DRUG LEAD COMPOUNDS The Regents of the University of California (US) 2001-01-10 EP disclosed
CN-1257486-A Oxazolidinone antibacterial agents with thiocarbonyl functionality UPJOHN CO (US) 2000-06-21 CN disclosed
WO-1999049314-A1 PHARMACOPHORE RECOMBINATION FOR THE IDENTIFICATION OF SMALL MOLECULE DRUG LEAD COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1999-09-30 WO disclosed
US-4293691-A Method for preparing magenta couplers having thioether groups FUJI PHOTO FILM CO., LTD. (JP) 1981-10-06 US disclosed